Ceragon Reports Third Quarter Earnings

Investing.com – Ceragon (NASDAQ: CRNT) reported third quarter EPS of $0.160, exceeding the analyst estimate of $0.090 by $0.07. Revenue for the quarter was $102.7M, slightly above the consensus estimate of $102.61M.

Guidance

Ceragon anticipates FY 2024 revenue between $390.000M and $400.000M, compared to the analyst consensus of $392.400M.

Ceragon's stock price closed at $2.56, reflecting a -11.110% decrease over the last three months, while increasing by 45.450% over the last twelve months.

In the last 90 days, Ceragon has seen 1 positive EPS revision and 0 negative revisions. For more details on Ceragon's stock price reactions to earnings, click here.

According to InvestingPro, Ceragon's Financial Health score is noted as "great performance".

Stay informed about upcoming earnings reports by checking out Investing.com's earnings calendar.